Genetic Localisation and Molecular Characterisation of Genes for Inherited Ataxias

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Localisation and Molecular Characterisation of Genes for Inherited Ataxias €)-t- o\ Genetic localisation and molecular characterisation of genes for inherited ataxias A thesis submitted for the degree of Doctor of Philosophy to the Uníversity of Adelaide by Kathryn Louise Friend (BSc) School of Medicine Department of Paediatrics, Womerls and Children s Hospital Adelaide July 2000 i Addendum Page iv; line 5: ARGF should read AGRF Page 21-; Change 4Í a" last patagraph to read: The identification of a disease causing mutation Tttiulty allows the assessment of mutations in this gene in other families with identical clinical symptoms. Identification of additional mutations will indicate genetic heterogeneity / homogenerty and further, provides appropriate confirmation of carier s tatus, presymptomatic and prenatal diagnosis Page 30; lines 9,L0,1L: Replace (AGC)" with (CAG)" Page 32; line L1: Replace Becher er al. 1997 with Irkeuchi et al. j.995 Page 35; end of line 25: Add - Anticipation was originally thought to be an artefact of Sgcertfn_ment (Peruose 1'945) and although the identification of triplet repeats identified a biological explanation it is possible that the apparent anticipÃtion seen in some families may still be due to ascertainment bias. Page 39; line 25: Replace inheritance with phenotype Page 40; end of last line: Add - (reviews; Hackam et aI. 1998; Paulson 1999; see Table ü-s) Page 54; line 3: Replace an with and Page 61; line 91: Replace are with of Page 79;line 1: Table 3-2 should read Table 3-6 Page 93; line L: Replace exclude with EXCLUDE Page 95; lines 28 and 29; Replace a strong hint of linkage with linkage Page'l'1'4; line 5: After undeterrrined., add - Sporadic cases of FHM may not be due to genetic defect. Page1,27; line 16: Replace (Table 5-1a) with (Table S-3) Page 1,31,; line 24: Replace (Table S-9) with (Table S-Z) last paragraph with - In summary, the xperiments and RED assay failed to give be responsible for the symptoms in S-CA Page1,68;1ine 12: Replace is with are Page 181; line 25: Add The individual in which the homozygous expansion at the FRDA locus was detected was subsequently deemed to have typical FRDA with later onset. Page 201.; ltne7 Add - Ikeuchi T, Koide R, Onodera O, Tanaka H, Oyake M, Takano FI, Tsuji S Dentatorubral-pallidoluysian atrophy (DRPLA). Molecular basis for wide clinical features of DRPLA. Clin Neurosci \995;3(1):23-7 Page 209; line 4 Add - Penrose LS The problem of anticipation in pedigrees of dystrophia myotoníca. Arìn Eugenics1'4:\25 -132. Response to reviewers comments Page 71,; Response to reviewer - Assumption of equal allele frequencies does not significantþ change lod scores attained thus it is valid to use equal allele frequencies. Page 92; Response to reviewer - The individual in question is coded as unlcrown for linkage analysis has phenotype which can be attríbuted to a car accident thus it is more valid to assign an urilmowïr phenotype rather than to assume this person to be a phenocopy. Pages 1.05,1.07; Response to reviewer - It is acknowledged that there are at least three loci for FHM. The intention of the candidate is to highlight the phenotypic heterogeneity for the CACNALA gene and to question whether other genes will be involved in these disorders with similar phenotypic heterogerreity. Page 109; Response to reviewer - Penetrance refers to expression of symptoms rather than variability of phenotype. Thus, in these pedigrees the penetrance is complete although the phenotype may vary. Page\L2; Response to reviewer - All othet affected individuals in EA-2 family (family 1) have episodic ataxia and no migraine. Individual III.1 has only migraine and thus most likely represents a variant phenotype. Given the early onset of episodic ataxia and the áge of this individual (33 years old) it ís not likely that this individual is presymptomatic, although it is possible that IIL1 may develop episodic ataxia. Acknowledgments I wish to thank all my colleagues in the Depattment of Cytogenetics and Molecular Genetics (WCH) for their ongoing support and friendship during these studies. In particular I thank: Marie Mangelsdorf for friendship, moral support, useful discussions and advice, meals at the pub late in the everring and pouring acrylamide gels at the end of the day; Hilary Phillips, Robyn Wallace and Georgina Hollway for their friendship, useful discussions and organisation of the microsatellite primer dilutions; Jo Crawford" Agi Gedeon, Oliva Handt, Sonia Dayans, Merran Finnis, Llmne Hobson, Scott Whitmore, Elizabeth Baker, Helen Eyre Erica Woollatt and Rosalie Smith for their friendship, words of wisdom and advice and good cheer during these studies - it was always a pleasure to share my working day with these people. I also wish to thank my supervisors Rob Richards and Grant Sutherland for discussions and critical appraisal of this thesis, John Mulley for useful and helpful discussions on linkage analysis and Liz Thompson for advice and proof reading of clinican aspects of this thesis. I thank the various clinicians, particularþ Drs E. Haan, G Suthers and E. Thompson and Ms S. White, for collecting family material and making it available for our use, and to the families themselves for their co-operation. I thank my parents for their encolüagement, support and love during these studies. Most importantly, I wish to sincereþ thank my husband, best friend and colleagae,lozef. Gecz lor his undying patience, love, inspiratiorç words of encouragement and support and always useful and informative discussions. And fi.,ully to our delightful daughter, Ellen, for her 40 minute naps which made finishing off this thesis take longer than I anticipated, and for her wonderful smiles which made me realise that it didn't matter. iii List of abbreviations The following list contains abbreviations used throughout the thesis: A adenosine Ab antibody ADCA autosomal dominant cerebellar ataxia ARGF Australian Genome Researdr Facility BAC bacterial artificial chromosome Blast Basic local align:rrent search tool bp base pair C cytosine cDNA complementary DNA CEPH Centre d'Etude de Polymorphism Humain CHCL Cooperative lfuman Linkage Centre cM centiMorgan dATP deoxy adenosine triphosphate dCTP deoxy cytosine triphosphate dGTP deoxy guanosine triphosphate DIRECT Direct identification of repeat expansions cloning technique DM myotonic dystrophy DNA deoxyribonucleic acid DRPLA Dentatorubral pallidoluysian atrophy dTTP deoxy thymidine triphosphate EA-1 episodic ataxia type 1 EA-2 episodic ataxia type2 EST expressed sequence tags FHM familial hemiplegic migraine FRDA Friedreich ataxia HD Huntington fisease IMVS Institute for Medical and Veterinary Science IOSCA Infantile onset of spinocerebellar ataxia LCL lymphoblast cell line Mb megabase MDE mutation detection enhancement MJD Machado-Joseph disease MRI magnetic reson€rnce i-ug-g NCBI national centre for biotechnology information NPCA non progressive cerebell,ar ataxia PAC PL artificial chromosome PCR polymerase chain reaction PIC polymorphic information content RACE rapid amplification of cDNA ends RED repeat expansion detection RFLP restriction fragment length polymorphism SBMA spinal-bulbar muscular atrophy scA (1-L0) spinocerebellar ataxia (1-10) SNP single nucleotide polymorphism sscA/P single strand conformation analysis / polymorphism URL uniform resource locatíon WB western blot WCH Women's and Childrerfs Hospital YAC yeast artificial chromosome iv SUMMARY: Inherited ataxias are genetically and clinically heterogeneous. They can be divided into several categories based on the following: inherited ataxias resulting from metabolic dysfunctiorç congenital ataxias, early onset ataxias and late onset ataxias. The last three groups, that is, the congenital, early and late onset ataxias are those which were examined in detail in this thesis. The congenital ataxias or non-progressive congenital ataxias (NPCAs) can be divíded into two groups, syndromal and pr;re. Although several gene localisations for the syndromal forms were lcrown when this study commenced no localisations for the pure NPCAs had been identified. DNA from a large family (PKS0248) segregating NPCA was collected and the gene localised by tinkage to the short arm of chromosome 3 (*itt a maximum two point lod score of 4.26 at 0:0 for D3S3630), Recombinant events in the family map the gene to an 18.9cM region distal to D3S1304. This represents the first genetic localisation for an autosomal dominant pure congenital ataxia. The candidate genes within this region are; inositol 1,4,5 -tiphosphate receptor type L (ITPRI), neural cell adhesion molecule (CALL) and plasmacytoma - associated neuronal glycoprotein (PANG), although these ate yet to be screened for mutations. It is anticipated that a mutation will be detected in one of these genes thus enabling molecular diagnosis for NPCA. The early onset ataxias include Friedreich ataxia, episodic ataxias and several cerebellar ataxias with distinct associated syndromal features. Nonsense mutations in CACNALA (a calcium charurel subunit) have been shown to cause episodic ataxia type 2 (EA-2). Interestingly, it has also been found that mutations in the same gene cause a late onset ataxía, SCA6, and familial hemiplegic migraine (FHM). Two mutations were identified in the CACNALA geneduring the course of these studies. The first of these was identified in a family with familial hemiplegic migraine. The mutation characterised in this family had been previously identified and reported in several other families and thus confirmed that this mutation was recurrent. The second mutation, identified in a family segregating Í.or EA-2, was a novel missense mutation in exon 32 of the CACNAI,A gene. This mutation represents the first missense mutation described for EA-2. It is intriguing that one individual in the family inherits the mutation and accompanying 'affected' haplotype but experiences V migraine alone, with no apparent symptoms of EA-2. This finding expands the spectrum of mutations shown to be responsible for EA-2. The final section of the thesis deals with the late onset spinocerebellar ataxias. This group of ataxias is the most genetically heterogeneous with eleven localisations identified by linkage studies.
Recommended publications
  • Y Chromosomes of the Proposed
    Sequencing and Annotating New Mammalian Y Chromosomes A White Paper Proposal, July, 2006 Steve Rozen1, Wesley C. Warren2, George Weinstock3, Stephen J. O’Brien4, Richard A. Gibbs3, Richard K. Wilson2, David C. Page1 1 Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142 2 Genome Sequencing Center, Washington University School of Medicine, St Louis, Missouri 63108 3 Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas 77030 4 Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702 Overview: Y chromosome sequence is essential for understanding human and mammalian evolution and biology The only Y chromosome that has been completely sequenced in any species is that of humans1,2, although sequencing of the chimpanzee and mouse Y chromosomes is in progress2-4. Here we propose to sequence and annotate the Y chromosomes of seven additional mammals at varying distances from human: Macaca mulatta (rhesus macaque) Callithrix jacchus (white-tufted-ear marmoset), Rattus norvegicus (laboratory rat), Bos taurus (domestic bull), Felis catus (domestic cat), Canis familiaris (dog), and Monodelphis domestica (laboratory opossum). We recognize that NHGRI approved rat Y chromosome sequencing as part of additional rat finishing5 and that the bull Y chromosome falls within the scope of the Bovine Genome Project, led by the Baylor sequencing center6. Inclusion of the rat and bull Y chromosomes is intended (i) to clarify collaborative intentions among the submitting sequencing centers (ii) to ensure coordination and agreement of the definitions of the most useful levels of completion of these chromosomes and (iii) to emphasize coherent biological rationales for sequencing and annotating the seven proposed Y chromosomes in terms of their relevance to human evolution, biology, and disease.
    [Show full text]
  • Characterization of X-Linked SNP Genotypic Variation in Globally Distributed Human Populations Genome Biology 2010, 11:R10
    Casto et al. Genome Biology 2010, 11:R10 http://genomebiology.com/2010/11/1/R10 RESEARCH Open Access CharacterizationResearch of X-Linked SNP genotypic variation in globally distributed human populations Amanda M Casto*1, Jun Z Li2, Devin Absher3, Richard Myers3, Sohini Ramachandran4 and Marcus W Feldman5 HumanAnhumanulation analysis structurepopulationsX-linked of X-linked variationand provides de geneticmographic insights variation patterns. into in pop- Abstract Background: The transmission pattern of the human X chromosome reduces its population size relative to the autosomes, subjects it to disproportionate influence by female demography, and leaves X-linked mutations exposed to selection in males. As a result, the analysis of X-linked genomic variation can provide insights into the influence of demography and selection on the human genome. Here we characterize the genomic variation represented by 16,297 X-linked SNPs genotyped in the CEPH human genome diversity project samples. Results: We found that X chromosomes tend to be more differentiated between human populations than autosomes, with several notable exceptions. Comparisons between genetically distant populations also showed an excess of X- linked SNPs with large allele frequency differences. Combining information about these SNPs with results from tests designed to detect selective sweeps, we identified two regions that were clear outliers from the rest of the X chromosome for haplotype structure and allele frequency distribution. We were also able to more precisely define the geographical extent of some previously described X-linked selective sweeps. Conclusions: The relationship between male and female demographic histories is likely to be complex as evidence supporting different conclusions can be found in the same dataset.
    [Show full text]
  • The Role of the Pro47ser Polymorphism of the Tr53 Gene in Predisposition to Breast Cancer
    The American Journal of Medical Sciences and Pharmaceutical Research IMPACT FACTOR – (ISSN 2689-1026) 2020: 5. 286 Published: December 30, 2020 | Pages: 64-73 OCLC - 1121105510 Doi: https://doi.org/10.37547/TAJMSPR/Volume02Issue12-11 The Role Of The Pro47ser Polymorphism Of The Tr53 Gene In Predisposition To Breast Cancer Nodirjon Shakhriqulovich Avezov Institute Of Biophysics And Biochemistry At The National University Of Uzbekistan, Tashkent, Uzbekistan Dilbar Abdullaevna Kodirova Journal Website: Institute Of Biophysics And Biochemistry At The National University Of Uzbekistan,Tashkent, http://usajournalshub.c om/index,php/TAJMSP Uzbekistan R Copyright: Original Khakimov Golib Abdullevich content from this work Republican Specialized Scientific-Practical Medical Center Of Oncology And Radiology, may be used under the terms of the creative Tashkent, Uzbekistan commons attributes 4.0 licence. Aminjon Karimovich Karimov Tashkent Pharmaceutical Institute, Uzbekistan Allomakhon Nizamovna Maksudova Tashkent Pharmaceutical Institute, Uzbekistan Mukhametamin Mametjanovich Shertaev Tashkent Pediatric Medical Institute, Uzbekistan Kodirjon Tukhtaboevich Boboev Republican Specialized Scientific And Practical Medical Center Of Hematology, Tashkent, Uzbekistan ABSTRACT Numerous scientific studies have been carried out on the predisposition of the Pro47Ser polymorphism of the TR53 gene to breast cancer in women living in most countries of the world. However, no studies have been conducted on the susceptibility of this Pro47Ser gene polymorphism to breast cancer in Uzbek women. In this article, genotyping of the Pro47Ser polymorphism of the TR53 gene was performed for the first time in 207 Uzbek women. According to the results of our study, the functionally dangerous T allele of the Pro47Ser polymorphism of the TR53 gene was statistically significantly higher than that in healthy donors in patients with breast cancer; (ch2 = 8.2; p = 0.004; OR = 11.2; 95% CI: 1.422-88.38; RR = 10.7; 95% CI: 1.382-82.82).
    [Show full text]
  • July, 13Th, 2006 [email protected] Course Bioinformatics II, Aug, 4-6, 2006
    Internet URL list Josef Maier Last updated: July, 13th, 2006 [email protected] Course Bioinformatics II, Aug, 4-6, 2006 Functional genomics Microarrays Microarray Bioinformatics at EBI http://www.ebi.ac.uk/microarray/index.html Arrayexpress at the EBI http://www.ebi.ac.uk/arrayexpress/ Expression Profiler at EBI http://www.ebi.ac.uk/expressionprofiler/ Documentation for Expression Profiler http://ep.ebi.ac.uk/Docs/ NCBI GEO Gene Expression Omnibus http://www.ncbi.nlm.nih.gov/geo/ Stanford Microarray Database http://genome-www5.stanford.edu/ Microarray Gene Expression Data Society http://www.mged.org/ Yale Microarray Database http://info.med.yale.edu/microarray/ TIGR functional genomics http://www.tigr.org/microarray NGFN German National Functional Genomics Network http://www.ngfn.de/ Genevestigator https://www.genevestigator.ethz.ch/ CATMA – A complete Arabidopsis Transcriptome MicroArray http://www.catma.org/ The Arabidopsis Information Resource - TAIR http://www.arabidopsis.org/ AFGN Arabidopsis Functional Genomics Network http://www.uni-tuebingen.de/plantphys/AFGN/ Microarray.Org – Microarray protocols and software http://microarray.org/sfgf/ NIH - Guide to Microarray Data analysis http://discover.nci.nih.gov/microarrayAnalysis/Microarray.Home.jsp Microarray Tools at NCI http://discover.nci.nih.gov/tools.jsp Cluster and Treeview from the Eisen Lab http://rana.lbl.gov/EisenSoftware.htm BioConductor Project - Open Source Software for Bioinformatics http://www.bioconductor.org/ Broad Institute Genecluster 2.0 http://www.broad.mit.edu/cancer/software/genecluster2/gc_license.html
    [Show full text]
  • Dosage-Sensitive Functions in Embryonic Development Drove the Survival of Genes on Sex-Specific Chromosomes in Snakes, Birds, and Mammals
    Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Research Dosage-sensitive functions in embryonic development drove the survival of genes on sex-specific chromosomes in snakes, birds, and mammals Daniel W. Bellott1 and David C. Page1,2,3 1Whitehead Institute, Cambridge, Massachusetts 02142, USA; 2Howard Hughes Medical Institute, Whitehead Institute, Cambridge, Massachusetts 02142, USA; 3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA Different ancestral autosomes independently evolved into sex chromosomes in snakes, birds, and mammals. In snakes and birds, females are ZW and males are ZZ; in mammals, females are XX and males are XY. Although X and Z Chromosomes retain nearly all ancestral genes, sex-specific W and Y Chromosomes suffered extensive genetic decay. In both birds and mammals, the genes that survived on sex-specific chromosomes are enriched for broadly expressed, dosage-sensitive regu- lators of gene expression, subject to strong purifying selection. To gain deeper insight into the processes that govern survival on sex-specific chromosomes, we carried out a meta-analysis of survival across 41 species—three snakes, 24 birds, and 14 mammals—doubling the number of ancestral genes under investigation and increasing our power to detect enrichments among survivors relative to nonsurvivors. Of 2564 ancestral genes, representing an eighth of the ancestral amniote genome, only 324 survive on present-day sex-specific chromosomes. Survivors are enriched for dosage-sensitive developmental pro- cesses, particularly development of neural crest–derived structures, such as the face. However, there was no enrichment for expression in sex-specific tissues, involvement in sex determination or gonadogenesis pathways, or conserved sex-biased ex- pression.
    [Show full text]
  • Chimpanzee and Human Y Chromosomes Are Remarkably Divergent in Structure and Gene Content
    Chimpanzee and Human Y Chromosomes Are Remarkably Divergent in Structure and Gene Content The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Hughes, Jennifer F. et al. “Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content.” Nature 463.7280 (2010): 536-539. As Published http://dx.doi.org/10.1038/nature08700 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/59332 Terms of Use Attribution-Noncommercial-Share Alike 3.0 Unported Detailed Terms http://creativecommons.org/licenses/by-nc-sa/3.0/ Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content Jennifer F. Hughes1, Helen Skaletsky1, Tatyana Pyntikova1, Tina A. Graves2, Saskia K. M. van Daalen3, Patrick J. Minx2, Robert S. Fulton2, Sean D. McGrath2, Devin P. Locke2, Cynthia Friedman4, Barbara J. Trask4, Elaine R. Mardis2, Wesley C. Warren2, Sjoerd Repping3, Steve Rozen1, Richard K. Wilson2, David C. Page1 1. Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. 2. The Genome Center, Washington University School of Medicine, St. Louis, Missouri, USA. 3. Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, the Netherlands. 4. Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 2 The human Y chromosome began to evolve from an autosome hundreds of millions of years ago, acquiring a sex-determining function and undergoing a series of inversions that suppressed crossing over with the X chromosome1,2.
    [Show full text]
  • August, 17Th, 2011 [email protected] Course Bioinformatics II, August 2011
    Internet URL list Josef Maier Last updated: August, 17th, 2011 [email protected] Course Bioinformatics II, August 2011 Functional genomics Transcriptomics databases Microarray Bioinformatics at EBI http://www.ebi.ac.uk/microarray/index.html Arrayexpress at the EBI http://www.ebi.ac.uk/arrayexpress/ Expression Profiler at EBI http://www.ebi.ac.uk/expressionprofiler/ Documentation for Expression Profiler http://www.bioinf.ebc.ee/EP/EP/ Gene Expression Atlas - Large Scale Meta-Analysis of Public Microarray Data http://www.ebi.ac.uk/gxa/ GEO Gene Expression Omnibus at NCBI http://www.ncbi.nlm.nih.gov/geo/ NCBI Sequence Read Archive http://www.ncbi.nlm.nih.gov/sra MaRe Microarray Retriever http://grenada.lumc.nl/HumaneGenetica/MaRe/ Stanford Microarray Database http://genome-www5.stanford.edu/ Yale Microarray Database http://info.med.yale.edu/microarray/ JCV Institute Genomics http://www.jcvi.org/cms/research/groups/ NIH ENCODE Project: ENCyclopedia Of DNA Elements http://www.genome.gov/10005107 NGFN German National Functional Genomics Network http://www.ngfn.de/ Genevestigator https://www.genevestigator.ethz.ch/ GeneCAT - Gene Co-expression Analysis Toolbox http://genecat.mpg.de/ CATMA - A complete Arabidopsis Transcriptome MicroArray http://www.catma.org/ The Arabidopsis Information Resource - TAIR http://www.arabidopsis.org/ AFGN Arabidopsis Functional Genomics Network http://www.uni-tuebingen.de/plantphys/AFGN/ Microarray Gene Expression Data Society http://www.mged.org/ Stanford Functional Genomics Facility http://microarray.org/sfgf/
    [Show full text]
  • Dosage-Sensitive Functions in Embryonic Development Drove the 4 Survival of Genes on Sex-Specific Chromosomes in Snakes, Birds, 5 and Mammals
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.09.196279; this version posted July 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Title Page 2 3 Dosage-sensitive functions in embryonic development drove the 4 survival of genes on sex-specific chromosomes in snakes, birds, 5 and mammals 6 7 Daniel W. Bellott1 and David C. Page1,2,3 8 1 Whitehead Institute, Cambridge, Massachusetts 02142, USA; 2 Department of 9 Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, 10 USA; 3 Howard Hughes Medical Institute, Whitehead Institute, Cambridge, 11 Massachusetts 02142, USA 12 13 Contact 14 Correspondence should be addressed to David C. Page ([email protected]) 15 Whitehead Institute, 455 Main Street Cambridge, MA 02142 USA 16 Telephone: (617) 258-5203 17 Running Title 18 Genes on W- and Y-chromosomes regulate development 19 (50 char. incl. spaces) 20 Key Words 21 comparative genomics, sex chromosomes, haploinsufficiency 22 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.09.196279; this version posted July 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 23 Abstract 24 Different ancestral autosomes independently evolved into sex chromosomes in 25 snakes, birds, and mammals.
    [Show full text]
  • Quantitative Analysis of Y-Chromosome Gene Expression Across 36 Human Tissues
    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Research Quantitative analysis of Y-Chromosome gene expression across 36 human tissues Alexander K. Godfrey,1,2 Sahin Naqvi,1,2 Lukáš Chmátal,1 Joel M. Chick,3 Richard N. Mitchell,4 Steven P. Gygi,3 Helen Skaletsky,1,5 and David C. Page1,2,5 1Whitehead Institute, Cambridge, Massachusetts 02142, USA; 2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; 3Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA; 4Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; 5Howard Hughes Medical Institute, Whitehead Institute, Cambridge, Massachusetts 02142, USA Little is known about how human Y-Chromosome gene expression directly contributes to differences between XX (female) and XY (male) individuals in nonreproductive tissues. Here, we analyzed quantitative profiles of Y-Chromosome gene ex- pression across 36 human tissues from hundreds of individuals. Although it is often said that Y-Chromosome genes are low- ly expressed outside the testis, we report many instances of elevated Y-Chromosome gene expression in a nonreproductive tissue. A notable example is EIF1AY, which encodes eukaryotic translation initiation factor 1A Y-linked, together with its X- linked homolog EIF1AX. Evolutionary loss of a Y-linked microRNA target site enabled up-regulation of EIF1AY, but not of EIF1AX, in the heart. Consequently, this essential translation initiation factor is nearly twice as abundant in male as in female heart tissue at the protein level. Divergence between the X and Y Chromosomes in regulatory sequence can therefore lead to tissue-specific Y-Chromosome-driven sex biases in expression of critical, dosage-sensitive regulatory genes.
    [Show full text]
  • A Gene-By-Gene Mosaic of Dosage Compensation Strategies on the Human X Chromosome Authors: Adrianna K
    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.09.455676; this version posted August 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Title: A gene-by-gene mosaic of dosage compensation strategies on the human X chromosome Authors: Adrianna K. San Roman1, Alexander K. Godfrey1,2, Helen Skaletsky1,3, Daniel W. Bellott1, Abigail F. Groff1, Laura V. Blanton1, Jennifer F. Hughes1, Laura Brown1,3, Sidaly Phou1,3, Ashley Buscetta4, Paul Kruszka4†, Nicole Banks4,5, Amalia Dutra6, Evgenia Pak6, Patricia C. Lasutschinkow7, Colleen Keen7, Shanlee M. Davis8, Nicole R. Tartaglia8,9, Carole Samango-Sprouse7,10, Maximilian Muenke4†, and David C. Page1,2,3* Affiliations: 1Whitehead Institute; Cambridge, MA 02142, USA. 2Department of Biology, Massachusetts Institute of Technology; Cambridge, MA 02139, USA. 3Howard Hughes Medical Institute, Whitehead Institute; Cambridge, MA 02142, USA. 4Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda; MD 20892, USA. 5Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; Bethesda, MD 20892 USA. 6Cytogenetics and Microscopy Core, National Human Genome Research Institute, National Institutes of Health; Bethesda, MD 20892 USA. 7Focus Foundation; Davidsonville, MD 21035, USA. 8Department of Pediatrics, University of Colorado School of Medicine; Aurora, CO 80045, USA. 9Developmental Pediatrics, eXtraOrdinarY Kids Program, Children’s Hospital Colorado, Auroroa, CO 80011, USA 10Department of Pediatrics, George Washington University; Washington, DC 20052, USA; Department of Human and Molecular Genetics, Florida International University, Miami, FL 33199, USA.
    [Show full text]
  • Genome-Wide Analysis of Cancer/Testis Gene Expression
    Genome-wide analysis of cancer/testis gene expression Oliver Hofmanna,b,1, Otavia L. Caballeroc, Brian J. Stevensond,e, Yao-Tseng Chenf, Tzeela Cohenc, Ramon Chuac, Christopher A. Maherb, Sumir Panjib, Ulf Schaeferb, Adele Krugerb, Minna Lehvaslaihob, Piero Carnincig,h, Yoshihide Hayashizakig,h, C. Victor Jongeneeld,e, Andrew J. G. Simpsonc, Lloyd J. Oldc,1, and Winston Hidea,b aDepartment of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, SPH2, 4th Floor, Boston, MA 02115; bSouth African National Bioinformatics Institute, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa; cLudwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; dLudwig Institute for Cancer Research, Lausanne Branch, 1015 Lausanne, Switzerland; eSwiss Institute of Bioinformatics, 1015 Lausanne, Switzerland; fWeill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021; gGenome Exploration Research Group (Genome Network Project Core Group), RIKEN Genomic Sciences Center (GSC), RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan; and hGenome Science Laboratory, Discovery Research Institute, RIKEN Wako Institute, 2-1 Hirosawa, Wako, Saitama, 3510198, Japan Contributed by Lloyd J. Old, October 28, 2008 (sent for review June 6, 2008) Cancer/Testis (CT) genes, normally expressed in germ line cells but expression profile information frequently limited to the original also activated in a wide range of cancer types, often encode defining articles. In some cases, e.g., ACRBP, the original antigens that are immunogenic in cancer patients, and present CT-restricted expression in normal tissues could not be con- potential for use as biomarkers and targets for immunotherapy.
    [Show full text]
  • Report of the Director, National Institutes of Health: Fiscal Years 2012 & 2013
    Report of the Director National Institutes of Health Fiscal Years 2012 & 2013 Report of the Director National Institutes of Health Fiscal Years 2012 & 2013 Preface This is the fourth National Institutes of Health (NIH) Biennial The chapter begins with a brief introduction describing Report, which is required by Section 403 of the Public the full continuum of biomedical research at NIH. The Health Service (PHS) Act. Appendix A provides the language research continuum moves from basic research to in the PHS Act that is relevant to this report. NIH’s goal is for preclinical translational research, clinical research, and this report to serve as a useful reference for understanding finally postclinical translational research. In partnership NIH activities and operations, and the agency welcomes with the other agencies of the U.S. Department of Health feedback on it. and Human Services (HHS), NIH aims to bring the rich evidence base of its research into clinical and community practice, ultimately turning discovery into health. The path Chapter Organization in the continuum is not strictly linear, because all steps of Chapter 1 opens with a statement from the Director of biomedical research can inform and relate to other areas. NIH assessing the state of biomedical and behavioral research. It then describes NIH structure, policies, and The introduction is followed by a summary of the NIH procedures, focusing on the operations of the extramural research portfolio relating to these research stages, across and intramural research programs; mechanisms for strategic all of the Institutes and Centers (ICs) and Office of the planning (including the activities and processes of the Director (OD) program offices.
    [Show full text]